Ocular Therapeutix (OCUL) Net Margin Growth (1y) (2015 - 2026)
Ocular Therapeutix (OCUL) Net Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -185.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -763.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 447.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 673.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,097.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -392.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2,208.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 29,636.00 |
| 10 | Ocular Therapeutix | 2.20 Bn | 2.20 Bn | 11.46 Mn | -9,032.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9,032.00 |
| Mar 31, 2026 | -24,552.00 |
| Dec 31, 2025 | -13,778.00 |
| Sep 30, 2025 | -18,489.00 |
| Jun 30, 2025 | -25,145.00 |
| Mar 31, 2025 | -31,437.00 |
| Dec 31, 2024 | -15,064.00 |
| Sep 30, 2024 | -14,037.00 |
| Jun 30, 2024 | -10,422.00 |
| Mar 31, 2024 | -9,761.00 |
| Dec 31, 2023 | -3,518.00 |
| Sep 30, 2023 | 5,061.00 |
| Jun 30, 2023 | 3,196.00 |
| Mar 31, 2023 | -2,976.00 |
| Dec 31, 2022 | -2,146.00 |
| Sep 30, 2022 | -1,842.00 |
| Jun 30, 2022 | 1,110.00 |
| Mar 31, 2022 | 15,036.00 |
| Dec 31, 2021 | 3,317.00 |
| Sep 30, 2021 | 9,317.00 |